16:28 IST
BSE
Results Update
Rossari Biotech Results Update
Rossari Biotech reported Q1 FY27 consolidated revenue of ₹697.2 crore, up 28% YoY. It also established a new 5,000 MTPA greenfield blending facility in Thailand.
Rossari Biotech Ltd
- Share price
- ₹423.20
- Market cap
- ₹2,344 Cr
- Revenue (annual)
- ₹2,396 Cr
- Net profit (annual)
- ₹149.2 Cr
- P/E (TTM)
- 15.6×Sector 37.2×
- Promoter holding
- 68.14%-0.01% QoQ
- FII holding
- 2.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Management Change 5Other Announcement 4Earnings Call 4Board Meeting Outcome 4Annual General Meeting 3Results Update 2Merger & Restructuring 2Financial Results 2Employee Stock Options 2Dividend 2Business Update 2Production Started 1Legal & Regulatory 1Capacity Expansion 1Board Meeting Date 1Annual Report 1
Time
2 announcements with these filters
13:56 IST
BSE
Results Update
Rossari Biotech Results Update
Rossari Biotech announced its FY26 results, reporting 15% revenue growth to ₹2,396.40 Crore. Q4 FY26 revenue reached a record ₹684.9 Crore, up 18% YoY, while annual PAT rose 9% to ₹149.2 Crore. The company also commissioned 15,000 MTPA additional capacity at its Dahej facility and recommended a ₹0.50 per share dividend.
- Value
- ₹2,396 Cr